NEW YORK (TheStreet) -- Bank of America/Merrill Lynch (BAC) upgraded Boston Scientific (BSX) to "buy" from "neutral" and set a $16 price target. The firm notes the stock has come off its highs, but the company has an attractive pipeline.
The stock was up 3.66% to $13.15 at 11:06 a.m. on Monday.
Must Read: Warren Buffett's 10 Favorite Growth Stocks
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts